Cargando…
Cognitive and negative symptoms in schizophrenia with L‐Carnosine adjuvant therapy – A randomized double‐blind placebo‐controlled study
The antioxidant L‐Carnosine is reported to improve negative and cognitive symptoms in Schizophrenia. A randomized double‐blind placebo‐controlled study was planned to study the effectiveness of adjuvant L‐Carnosine therapy in patients with Schizophrenia. 100 eligible patients with predominant negati...
Autores principales: | Tharoor, Hema, Maran, Sindhu, Chandan, Antra K., Pari, Manikandan, Rao, Shruti, Durairaj, Jothilakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031293/ https://www.ncbi.nlm.nih.gov/pubmed/36946070 http://dx.doi.org/10.1002/prp2.1074 |
Ejemplares similares
-
Role of Novel Dietary Supplement N-acetyl Cysteine in Treating Negative Symptoms in Schizophrenia: A 6-Month Follow-up Study
por: Tharoor, Hema, et al.
Publicado: (2018) -
Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives
por: Tharoor, Hema, et al.
Publicado: (2015) -
Factors associated with age of onset of illness among patients with schizophrenia: A cross-sectional study from South India
por: Pavithra, A, et al.
Publicado: (2022) -
Sexual dysfunctions in schizophrenia: Professionals and patients perspectives
por: Tharoor, Hema, et al.
Publicado: (2015) -
Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arabzadeh, Somaye, et al.
Publicado: (2018)